MATINAS BIOPHARMA HOLDINGS, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, other for the quarter ending 2025-12-31 was -$288.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, other for the quarter ending 2025-09-30 was $618.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, other for the quarter ending 2025-06-30 was $309.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, other for the quarter ending 2025-03-31 was $21.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, other for fiscal 2025 was $330.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, other for fiscal 2022 was $291.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, other for fiscal 2016 was $315.00K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2025-12-31 | -$288.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $330.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $618.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $309.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $21.00K 10-Q · filed 2026-05-08 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $291.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | |
| 2022-03-31 | $291.00K 10-Q · filed 2023-05-10 | |
| 2020-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | |
| 2020-03-31 | $46.69M 10-Q · filed 2021-05-10 | |
| 2016-12-31 | $315.00K 10-K · filed 2018-03-16 | |
| 2015-03-31 | $4.28M 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |